Belite Bio (BLTE) Interest Coverage Ratio (2022 - 2025)
Belite Bio's (BLTE) quarterly Interest Coverage Ratio came in at 0.0 in Q4 2025, up 99.59% year-on-year from 0.0 in Q4 2024, and up 99.59% quarter-over-quarter from 0.02 in Q4 2024.
Belite Bio (BLTE) Interest Coverage Ratio (2022 - 2025) Analysis & Trends
Belite Bio's Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 99.59% year-over-year to 0.0 in Q4 2025; TTM through Dec 2025 was 43189.93, a 39.92% decrease from a year earlier, with the FY2025 full-year figure at 0.23, down 60.01% from the prior year.
- Interest Coverage Ratio improved to 0.0 in Q4 2025 per BLTE's latest filing, from 0.02 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.0 in Q4 2025 and bottomed at 20.04 in Q4 2023.
- The 4-year median for Interest Coverage Ratio is 0.33 (2022), against an average of 5.18.
- Across the five-year window, Interest Coverage Ratio sank 3023.24% in 2023 and jumped 99.91% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.64 in 2022, then tumbled by 3023.24% to 20.04 in 2023, then soared by 99.91% to 0.02 in 2024, then jumped by 99.59% to 0.0 in 2025.
- Per Business Quant, the three latest BLTE Interest Coverage Ratio figures stand at 0.0 (Q4 2025), 0.02 (Q4 2024), and 20.04 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.02 |
| Dec 31, 2023 | -20.04 |
| Dec 31, 2022 | -0.64 |